APO Research
Talk to an analyst

APO RESEARCH · REPORT

NK-1 Receptor Antagonists

Compare research editions
View pricing & licenses

Selected research

Industry Growth & Trends

Global NK-1 Receptor Antagonists Industry Growth and Trends Forecast to 2032

28 December 2025121 pages

Choose your research edition.

Industry ResearchNK-1 Receptor Antagonists Industry Research Report 2026146 pages · $2,950 USDIndustry Growth & TrendsGlobal NK-1 Receptor Antagonists Industry Growth and Trends Forecast to 2032121 pages · $3,450 USDMarket StructureGlobal NK-1 Receptor Antagonists Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032196 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal NK-1 Receptor Antagonists Market Outlook and Growth Opportunities 2026203 pages · $4,250 USDMarket Analysis & ForecastGlobal NK-1 Receptor Antagonists Market Analysis and Forecast 2026-2032208 pages · $4,950 USD

Market perspective

The global NK-1 Receptor Antagonists market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The North America market for NK-1 Receptor Antagonists is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.

The Europe market for NK-1 Receptor Antagonists is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for NK-1 Receptor Antagonists is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of NK-1 Receptor Antagonists include Dr. Reddy's Laboratories, Eugia Pharma, Fresenius Kabi, Glenmark, Helsinn Healthcare, Heron Therapeutics, Lupin, MSN and Mylan, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report provides a structured, data-driven view of the global NK-1 Receptor Antagonists market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The NK-1 Receptor Antagonists market size, estimates, and forecasts are presented in terms of sales volume (K Units) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global NK-1 Receptor Antagonists market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to NK-1 Receptor Antagonists.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading manufacturers in the global NK-1 Receptor Antagonists market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

NK-1 Receptor Antagonists Market by Company

Dr. Reddy's Laboratories

Eugia Pharma

Fresenius Kabi

Glenmark

Helsinn Healthcare

Heron Therapeutics

Lupin

MSN

Mylan

Steriscience

TerSera Therapeutics

Teva

Torrent Pharmaceuticals

Beijing Sihuan Pharmaceutical

Hansoh Pharma

Merck

Qilu Pharmaceutical

Sandoz

Yichang Humanwell Pharmaceutical

Chia Tai Tianqing Pharmaceutical

NK-1 Receptor Antagonists Segment by Type

Netupitant

Maropitant

Rolapitant

Fosaprepitant

Aprepitant

Other

NK-1 Receptor Antagonists Segment by Application

Chemotherapy-induced Nausea and Vomiting (CINV)

Postoperative Nausea and Vomiting (PONV)

Other

NK-1 Receptor Antagonists Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global NK-1 Receptor Antagonists market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of NK-1 Receptor Antagonists and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of NK-1 Receptor Antagonists.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of NK-1 Receptor Antagonists manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Sales, revenue of NK-1 Receptor Antagonists in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.

Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.

Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.

Chapter 13: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Major Company of Netupitant Table 2. Major Company of Maropitant Table 3. Major Company of Rolapitant Table 4. Major Company of Fosaprepitant Table 5. Major Company of Aprepitant Table 6. Major Company of Other Table 7. Global NK-1 Receptor Antagonists Sales by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 8. Global NK-1 Receptor Antagonists Sales by Type (2021-2026) & (K Units) Table 9. Global NK-1 Receptor Antagonists Sales Market Share in Volume by Type (2021-2026) Table 10. Global NK-1 Receptor Antagonists Sales by Type (2021-2026) & (US$ Million) Table 11. Global NK-1 Receptor Antagonists Sales Market Share in Value by Type (2021-2026) Table 12. Global NK-1 Receptor Antagonists Price by Type (2021-2026) & (US$/Unit) Table 13. Global NK-1 Receptor Antagonists Sales by Type (2027-2032) & (K Units) Table 14. Global NK-1 Receptor Antagonists Sales Market Share in Volume by Type (2027-2032) Table 15. Global NK-1 Receptor Antagonists Sales by Type (2027-2032) & (US$ Million) Table 16. Global NK-1 Receptor Antagonists Sales Market Share in Value by Type (2027-2032) Table 17. Global NK-1 Receptor Antagonists Price by Type (2027-2032) & (US$/Unit) Table 18. North America NK-1 Receptor Antagonists Sales by Type (2021-2026) & (K Units) Table 19. North America NK-1 Receptor Antagonists Sales by Type (2021-2026) & (US$ Million) Table 20. Europe NK-1 Receptor Antagonists Sales by Type (2021-2026) & (K Units) Table 21. Europe NK-1 Receptor Antagonists Sales by Type (2021-2026) & (US$ Million) Table 22. Asia-Pacific NK-1 Receptor Antagonists Sales by Type (2021-2026) & (K Units) Table 23. Asia-Pacific NK-1 Receptor Antagonists Sales by Type (2021-2026) & (US$ Million) Table 24. Latin America NK-1 Receptor Antagonists Sales by Type (2021-2026) & (K Units) Table 25. Latin America NK-1 Receptor Antagonists Sales by Type (2021-2026) & (US$ Million) Table 26. Middle East and Africa NK-1 Receptor Antagonists Sales by Type (2021-2026) & (K Units) Table 27. Middle East and Africa NK-1 Receptor Antagonists Sales by Type (2021-2026) & (US$ Million) Table 28. NK-1 Receptor Antagonists Industry Trends Table 29. NK-1 Receptor Antagonists Industry Drivers Table 30. NK-1 Receptor Antagonists Industry Opportunities and Challenges Table 31. NK-1 Receptor Antagonists Industry Restraints Table 32. Global NK-1 Receptor Antagonists Sales Revenue by Company (US$ Million) & (2021-2026) Table 33. Global NK-1 Receptor Antagonists Revenue Market Share by Company (2021-2026) Table 34. Global NK-1 Receptor Antagonists Sales by Company (2021-2026) & (K Units) Table 35. Global NK-1 Receptor Antagonists Sales Share by Company (2021-2026) Table 36. Global NK-1 Receptor Antagonists Market Price by Company (2021-2026) & (US$/Unit) Table 37. Global NK-1 Receptor Antagonists Industry Company Ranking, 2024 VS 2025 VS 2026 Table 38. Global NK-1 Receptor Antagonists Major Company Production Sites and Headquarters Table 39. Global NK-1 Receptor Antagonists Company, Product Type & Application Table 40. Global NK-1 Receptor Antagonists Company Establishment Date Table 41. Global Company Market Concentration Ratio (CR5 and HHI) Table 42. Global NK-1 Receptor Antagonists by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 43. Global NK-1 Receptor Antagonists Market Size Comparison by Region (US$ Million): 2021 VS 2025 VS 2032 Table 44. Global NK-1 Receptor Antagonists Sales by Region (2021-2026) & (K Units) Table 45. Global NK-1 Receptor Antagonists Sales Market Share in Volume by Region (2021-2026) Table 46. Global NK-1 Receptor Antagonists Sales by Region (2021-2026) & (US$ Million) Table 47. Global NK-1 Receptor Antagonists Sales Market Share in Value by Region (2021-2026) Table 48. Global NK-1 Receptor Antagonists Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 49. Global NK-1 Receptor Antagonists Sales by Region (2027-2032) & (K Units) Table 50. Global NK-1 Receptor Antagonists Sales Market Share in Volume by Region (2027-2032) Table 51. Global NK-1 Receptor Antagonists Sales by Region (2027-2032) & (US$ Million) Table 52. Global NK-1 Receptor Antagonists Sales Market Share in Value by Region (2027-2032) Table 53. Global NK-1 Receptor Antagonists Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2027-2032) Table 54. Global NK-1 Receptor Antagonists Sales by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 55. Global NK-1 Receptor Antagonists Sales by Application (2021-2026) & (K Units) Table 56. Global NK-1 Receptor Antagonists Sales Market Share in Volume by Application (2021-2026) Table 57. Global NK-1 Receptor Antagonists Sales by Application (2021-2026) & (US$ Million) Table 58. Global NK-1 Receptor Antagonists Sales Market Share in Value by Application (2021-2026) Table 59. Global NK-1 Receptor Antagonists Price by Application (2021-2026) & (US$/Unit) Table 60. Global NK-1 Receptor Antagonists Sales by Application (2027-2032) & (K Units) Table 61. Global NK-1 Receptor Antagonists Sales Market Share in Volume by Application (2027-2032) Table 62. Global NK-1 Receptor Antagonists Sales by Application (2027-2032) & (US$ Million) Table 63. Global NK-1 Receptor Antagonists Sales Market Share in Value by Application (2027-2032) Table 64. Global NK-1 Receptor Antagonists Price by Application (2027-2032) & (US$/Unit) Table 65. North America NK-1 Receptor Antagonists Sales by Application (2021-2026) & (K Units) Table 66. North America NK-1 Receptor Antagonists Sales by Application (2021-2026) & (US$ Million) Table 67. Europe NK-1 Receptor Antagonists Sales by Application (2021-2026) & (K Units) Table 68. Europe NK-1 Receptor Antagonists Sales by Application (2021-2026) & (US$ Million) Table 69. Asia-Pacific NK-1 Receptor Antagonists Sales by Application (2021-2026) & (K Units) Table 70. Asia-Pacific NK-1 Receptor Antagonists Sales by Application (2021-2026) & (US$ Million) Table 71. Latin America NK-1 Receptor Antagonists Sales by Application (2021-2026) & (K Units) Table 72. Latin America NK-1 Receptor Antagonists Sales by Application (2021-2026) & (US$ Million) Table 73. Middle East and Africa NK-1 Receptor Antagonists Sales by Application (2021-2026) & (K Units) Table 74. Middle East and Africa NK-1 Receptor Antagonists Sales by Application (2021-2026) & (US$ Million) Table 75. Dr. Reddy's Laboratories Company Information Table 76. Dr. Reddy's Laboratories Business Overview Table 77. Dr. Reddy's Laboratories NK-1 Receptor Antagonists Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 78. Dr. Reddy's Laboratories NK-1 Receptor Antagonists Product Portfolio Table 79. Dr. Reddy's Laboratories Recent Development Table 80. Eugia Pharma Company Information Table 81. Eugia Pharma Business Overview Table 82. Eugia Pharma NK-1 Receptor Antagonists Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 83. Eugia Pharma NK-1 Receptor Antagonists Product Portfolio Table 84. Eugia Pharma Recent Development Table 85. Fresenius Kabi Company Information Table 86. Fresenius Kabi Business Overview Table 87. Fresenius Kabi NK-1 Receptor Antagonists Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 88. Fresenius Kabi NK-1 Receptor Antagonists Product Portfolio Table 89. Fresenius Kabi Recent Development Table 90. Glenmark Company Information Table 91. Glenmark Business Overview Table 92. Glenmark NK-1 Receptor Antagonists Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 93. Glenmark NK-1 Receptor Antagonists Product Portfolio Table 94. Glenmark Recent Development Table 95. Helsinn Healthcare Company Information Table 96. Helsinn Healthcare Business Overview Table 97. Helsinn Healthcare NK-1 Receptor Antagonists Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 98. Helsinn Healthcare NK-1 Receptor Antagonists Product Portfolio Table 99. Helsinn Healthcare Recent Development Table 100. Heron Therapeutics Company Information Table 101. Heron Therapeutics Business Overview Table 102. Heron Therapeutics NK-1 Receptor Antagonists Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 103. Heron Therapeutics NK-1 Receptor Antagonists Product Portfolio Table 104. Heron Therapeutics Recent Development Table 105. Lupin Company Information Table 106. Lupin Business Overview Table 107. Lupin NK-1 Receptor Antagonists Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 108. Lupin NK-1 Receptor Antagonists Product Portfolio Table 109. Lupin Recent Development Table 110. MSN Company Information Table 111. MSN Business Overview Table 112. MSN NK-1 Receptor Antagonists Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 113. MSN NK-1 Receptor Antagonists Product Portfolio Table 114. MSN Recent Development Table 115. Mylan Company Information Table 116. Mylan Business Overview Table 117. Mylan NK-1 Receptor Antagonists Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 118. Mylan NK-1 Receptor Antagonists Product Portfolio Table 119. Mylan Recent Development Table 120. Steriscience Company Information Table 121. Steriscience Business Overview Table 122. Steriscience NK-1 Receptor Antagonists Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 123. Steriscience NK-1 Receptor Antagonists Product Portfolio Table 124. Steriscience Recent Development Table 125. TerSera Therapeutics Company Information Table 126. TerSera Therapeutics Business Overview Table 127. TerSera Therapeutics NK-1 Receptor Antagonists Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 128. TerSera Therapeutics NK-1 Receptor Antagonists Product Portfolio Table 129. TerSera Therapeutics Recent Development Table 130. Teva Company Information Table 131. Teva Business Overview Table 132. Teva NK-1 Receptor Antagonists Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 133. Teva NK-1 Receptor Antagonists Product Portfolio Table 134. Teva Recent Development Table 135. Torrent Pharmaceuticals Company Information Table 136. Torrent Pharmaceuticals Business Overview Table 137. Torrent Pharmaceuticals NK-1 Receptor Antagonists Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 138. Torrent Pharmaceuticals NK-1 Receptor Antagonists Product Portfolio Table 139. Torrent Pharmaceuticals Recent Development Table 140. Beijing Sihuan Pharmaceutical Company Information Table 141. Beijing Sihuan Pharmaceutical Business Overview Table 142. Beijing Sihuan Pharmaceutical NK-1 Receptor Antagonists Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 143. Beijing Sihuan Pharmaceutical NK-1 Receptor Antagonists Product Portfolio Table 144. Beijing Sihuan Pharmaceutical Recent Development Table 145. Hansoh Pharma Company Information Table 146. Hansoh Pharma Business Overview Table 147. Hansoh Pharma NK-1 Receptor Antagonists Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 148. Hansoh Pharma NK-1 Receptor Antagonists Product Portfolio Table 149. Hansoh Pharma Recent Development Table 150. Merck Company Information Table 151. Merck Business Overview Table 152. Merck NK-1 Receptor Antagonists Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 153. Merck NK-1 Receptor Antagonists Product Portfolio Table 154. Merck Recent Development Table 155. Qilu Pharmaceutical Company Information Table 156. Qilu Pharmaceutical Business Overview Table 157. Qilu Pharmaceutical NK-1 Receptor Antagonists Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 158. Qilu Pharmaceutical NK-1 Receptor Antagonists Product Portfolio Table 159. Qilu Pharmaceutical Recent Development Table 160. Sandoz Company Information Table 161. Sandoz Business Overview Table 162. Sandoz NK-1 Receptor Antagonists Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 163. Sandoz NK-1 Receptor Antagonists Product Portfolio Table 164. Sandoz Recent Development Table 165. Yichang Humanwell Pharmaceutical Company Information Table 166. Yichang Humanwell Pharmaceutical Business Overview Table 167. Yichang Humanwell Pharmaceutical NK-1 Receptor Antagonists Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 168. Yichang Humanwell Pharmaceutical NK-1 Receptor Antagonists Product Portfolio Table 169. Yichang Humanwell Pharmaceutical Recent Development Table 170. Chia Tai Tianqing Pharmaceutical Company Information Table 171. Chia Tai Tianqing Pharmaceutical Business Overview Table 172. Chia Tai Tianqing Pharmaceutical NK-1 Receptor Antagonists Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 173. Chia Tai Tianqing Pharmaceutical NK-1 Receptor Antagonists Product Portfolio Table 174. Chia Tai Tianqing Pharmaceutical Recent Development Table 175. North America NK-1 Receptor Antagonists Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 176. North America NK-1 Receptor Antagonists Sales by Country (2021-2026) & (K Units) Table 177. North America NK-1 Receptor Antagonists Sales Market Share by Country (2021-2026) Table 178. North America NK-1 Receptor Antagonists Sales Forecast by Country (2027-2032) & (K Units) Table 179. North America NK-1 Receptor Antagonists Sales Market Share Forecast by Country (2027-2032) Table 180. North America NK-1 Receptor Antagonists Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 181. North America NK-1 Receptor Antagonists Market Size by Country (2021-2026) & (US$ Million) Table 182. North America NK-1 Receptor Antagonists Market Share by Country (2021-2026) Table 183. North America NK-1 Receptor Antagonists Market Size Forecast by Country (2027-2032) & (US$ Million) Table 184. North America NK-1 Receptor Antagonists Market Share Forecast by Country (2027-2032) Table 185. Europe NK-1 Receptor Antagonists Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 186. Europe NK-1 Receptor Antagonists Sales by Country (2021-2026) & (K Units) Table 187. Europe NK-1 Receptor Antagonists Sales Market Share by Country (2021-2026) Table 188. Europe NK-1 Receptor Antagonists Sales Forecast by Country (2027-2032) & (K Units) Table 189. Europe NK-1 Receptor Antagonists Sales Market Share Forecast by Country (2027-2032) Table 190. Europe NK-1 Receptor Antagonists Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 191. Europe NK-1 Receptor Antagonists Market Size by Country (2021-2026) & (US$ Million) Table 192. Europe NK-1 Receptor Antagonists Market Share by Country (2021-2026) Table 193. Europe NK-1 Receptor Antagonists Market Size Forecast by Country (2027-2032) & (US$ Million) Table 194. Europe NK-1 Receptor Antagonists Market Share Forecast by Country (2027-2032) Table 195. Asia-Pacific NK-1 Receptor Antagonists Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 196. Asia-Pacific NK-1 Receptor Antagonists Sales by Country (2021-2026) & (K Units) Table 197. Asia-Pacific NK-1 Receptor Antagonists Sales Market Share by Country (2021-2026) Table 198. Asia-Pacific NK-1 Receptor Antagonists Sales Forecast by Country (2027-2032) & (K Units) Table 199. Asia-Pacific NK-1 Receptor Antagonists Sales Market Share Forecast by Country (2027-2032) Table 200. Asia-Pacific NK-1 Receptor Antagonists Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 201. Asia-Pacific NK-1 Receptor Antagonists Market Size by Country (2021-2026) & (US$ Million) Table 202. Asia-Pacific NK-1 Receptor Antagonists Market Share by Country (2021-2026) Table 203. Asia-Pacific NK-1 Receptor Antagonists Market Size Forecast by Country (2027-2032) & (US$ Million) Table 204. Asia-Pacific NK-1 Receptor Antagonists Market Share Forecast by Country (2027-2032) Table 205. Latin America NK-1 Receptor Antagonists Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 206. Latin America NK-1 Receptor Antagonists Sales by Country (2021-2026) & (K Units) Table 207. Latin America NK-1 Receptor Antagonists Sales Market Share by Country (2021-2026) Table 208. Latin America NK-1 Receptor Antagonists Sales Forecast by Country (2027-2032) & (K Units) Table 209. Latin America NK-1 Receptor Antagonists Sales Market Share Forecast by Country (2027-2032) Table 210. Latin America NK-1 Receptor Antagonists Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 211. Latin America NK-1 Receptor Antagonists Market Size by Country (2021-2026) & (US$ Million) Table 212. Latin America NK-1 Receptor Antagonists Market Share by Country (2021-2026) Table 213. Latin America NK-1 Receptor Antagonists Market Size Forecast by Country (2027-2032) & (US$ Million) Table 214. Latin America NK-1 Receptor Antagonists Market Share Forecast by Country (2027-2032) Table 215. Middle East and Africa NK-1 Receptor Antagonists Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 216. Middle East and Africa NK-1 Receptor Antagonists Sales by Country (2021-2026) & (K Units) Table 217. Middle East and Africa NK-1 Receptor Antagonists Sales Market Share by Country (2021-2026) Table 218. Middle East and Africa NK-1 Receptor Antagonists Sales Forecast by Country (2027-2032) & (K Units) Table 219. Middle East and Africa NK-1 Receptor Antagonists Sales Market Share Forecast by Country (2027-2032) Table 220. Middle East and Africa NK-1 Receptor Antagonists Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 221. Middle East and Africa NK-1 Receptor Antagonists Market Size by Country (2021-2026) & (US$ Million) Table 222. Middle East and Africa NK-1 Receptor Antagonists Market Share by Country (2021-2026) Table 223. Middle East and Africa NK-1 Receptor Antagonists Market Size Forecast by Country (2027-2032) & (US$ Million) Table 224. Middle East and Africa NK-1 Receptor Antagonists Market Share Forecast by Country (2027-2032) Table 225. Key Raw Materials Table 226. Raw Materials Key Suppliers Table 227. NK-1 Receptor Antagonists Distributors List Table 228. NK-1 Receptor Antagonists Customers List Table 229. Research Programs/Design for This Report Table 230. Authors List of This Report Table 231. Secondary Sources Table 232. Primary Sources List of Figures Figure 1. NK-1 Receptor Antagonists Image Figure 2. Global NK-1 Receptor Antagonists Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global NK-1 Receptor Antagonists Market Size (2021-2032) & (US$ Million) Figure 4. Global NK-1 Receptor Antagonists Sales (2021-2032) & (K Units) Figure 5. Netupitant Image Figure 6. Global Netupitant Sales YoY Growth (2021-2032) & (K Units) Figure 7. Maropitant Image Figure 8. Global Maropitant Sales YoY Growth (2021-2032) & (K Units) Figure 9. Rolapitant Image Figure 10. Global Rolapitant Sales YoY Growth (2021-2032) & (K Units) Figure 11. Fosaprepitant Image Figure 12. Global Fosaprepitant Sales YoY Growth (2021-2032) & (K Units) Figure 13. Aprepitant Image Figure 14. Global Aprepitant Sales YoY Growth (2021-2032) & (K Units) Figure 15. Other Image Figure 16. Global Other Sales YoY Growth (2021-2032) & (K Units) Figure 17. Global NK-1 Receptor Antagonists Market Size Overview by Type (2021-2032) & (US$ Million) Figure 18. Global NK-1 Receptor Antagonists Market Share by Type 2025 VS 2032 Figure 19. North America NK-1 Receptor Antagonists Sales Market Share in Volume by Type in 2025 Figure 20. North America NK-1 Receptor Antagonists Sales Market Share in Value by Type in 2025 Figure 21. Europe NK-1 Receptor Antagonists Sales Market Share in Volume by Type in 2025 Figure 22. Europe NK-1 Receptor Antagonists Sales Market Share in Value by Type in 2025 Figure 23. Asia-Pacific NK-1 Receptor Antagonists Sales Market Share in Volume by Type in 2025 Figure 24. Asia-Pacific NK-1 Receptor Antagonists Sales Market Share in Value by Type in 2025 Figure 25. Latin America NK-1 Receptor Antagonists Sales Market Share in Volume by Type in 2025 Figure 26. Latin America NK-1 Receptor Antagonists Sales Market Share in Value by Type in 2025 Figure 27. Middle East and Africa NK-1 Receptor Antagonists Sales Market Share in Volume by Type in 2025 Figure 28. Middle East and Africa NK-1 Receptor Antagonists Sales Market Share in Value by Type in 2025 Figure 29. Global Top 5 and 10 NK-1 Receptor Antagonists Players Market Share by Revenue in 2025 Figure 30. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 31. Chemotherapy-induced Nausea and Vomiting (CINV) Image Figure 32. Global Chemotherapy-induced Nausea and Vomiting (CINV) Sales YoY Growth (2021-2032) & (K Units) Figure 33. Postoperative Nausea and Vomiting (PONV) Image Figure 34. Global Postoperative Nausea and Vomiting (PONV) Sales YoY Growth (2021-2032) & (K Units) Figure 35. Other Image Figure 36. Global Other Sales YoY Growth (2021-2032) & (K Units) Figure 37. Global NK-1 Receptor Antagonists Market Size Overview by Application (2021-2032) & (US$ Million) Figure 38. Global NK-1 Receptor Antagonists Market Share by Application 2025 VS 2032 Figure 39. North America NK-1 Receptor Antagonists Sales Market Share in Volume by Application in 2025 Figure 40. North America NK-1 Receptor Antagonists Sales Market Share in Value by Application in 2025 Figure 41. Europe NK-1 Receptor Antagonists Sales Market Share in Volume by Application in 2025 Figure 42. Europe NK-1 Receptor Antagonists Sales Market Share in Value by Application in 2025 Figure 43. Asia-Pacific NK-1 Receptor Antagonists Sales Market Share in Volume by Application in 2025 Figure 44. Asia-Pacific NK-1 Receptor Antagonists Sales Market Share in Value by Application in 2025 Figure 45. Latin America NK-1 Receptor Antagonists Sales Market Share in Volume by Application in 2025 Figure 46. Latin America NK-1 Receptor Antagonists Sales Market Share in Value by Application in 2025 Figure 47. Middle East and Africa NK-1 Receptor Antagonists Sales Market Share in Volume by Application in 2025 Figure 48. Middle East and Africa NK-1 Receptor Antagonists Sales Market Share in Value by Application in 2025 Figure 49. North America NK-1 Receptor Antagonists Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 50. North America NK-1 Receptor Antagonists Sales Share by Country: 2021 VS 2025 VS 2032 Figure 51. North America NK-1 Receptor Antagonists Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 52. North America NK-1 Receptor Antagonists Market Share by Country: 2021 VS 2025 VS 2032 Figure 53. Europe NK-1 Receptor Antagonists Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 54. Europe NK-1 Receptor Antagonists Sales Share by Country: 2021 VS 2025 VS 2032 Figure 55. Europe NK-1 Receptor Antagonists Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 56. Europe NK-1 Receptor Antagonists Market Share by Country: 2021 VS 2025 VS 2032 Figure 57. Asia-Pacific NK-1 Receptor Antagonists Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 58. Asia-Pacific NK-1 Receptor Antagonists Sales Share by Country: 2021 VS 2025 VS 2032 Figure 59. Asia-Pacific NK-1 Receptor Antagonists Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 60. Asia-Pacific NK-1 Receptor Antagonists Market Share by Country: 2021 VS 2025 VS 2032 Figure 61. Latin America NK-1 Receptor Antagonists Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 62. Latin America NK-1 Receptor Antagonists Sales Share by Country: 2021 VS 2025 VS 2032 Figure 63. Latin America NK-1 Receptor Antagonists Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 64. Latin America NK-1 Receptor Antagonists Market Share by Country: 2021 VS 2025 VS 2032 Figure 65. Middle East and Africa NK-1 Receptor Antagonists Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 66. Middle East and Africa NK-1 Receptor Antagonists Sales Share by Country: 2021 VS 2025 VS 2032 Figure 67. Middle East and Africa NK-1 Receptor Antagonists Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 68. Middle East and Africa NK-1 Receptor Antagonists Market Share by Country: 2021 VS 2025 VS 2032 Figure 69. NK-1 Receptor Antagonists Value Chain Figure 70. Key Raw Materials Price Figure 71. Manufacturing Cost Structure Figure 72. NK-1 Receptor Antagonists Production Mode & Process Figure 73. Direct Comparison with Distribution Share Figure 74. Distributors Profiles Figure 75. Years Considered Figure 76. Research Process Figure 77. Key Executives Interviewed

Scope & coverage.

Types
  • Netupitant
  • Maropitant
  • Rolapitant
  • Fosaprepitant
  • Aprepitant
  • Other
Applications
  • Chemotherapy-induced Nausea and Vomiting (CINV)
  • Postoperative Nausea and Vomiting (PONV)
  • Other
Companies covered
  • Dr. Reddy's Laboratories
  • Eugia Pharma
  • Fresenius Kabi
  • Glenmark
  • Helsinn Healthcare
  • Heron Therapeutics
  • Lupin
  • MSN
  • Mylan
  • Steriscience
  • TerSera Therapeutics
  • Teva
  • Torrent Pharmaceuticals
  • Beijing Sihuan Pharmaceutical
  • Hansoh Pharma
  • Merck
  • Qilu Pharmaceutical
  • Sandoz
  • Yichang Humanwell Pharmaceutical
  • Chia Tai Tianqing Pharmaceutical

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global NK-1 Receptor Antagonists Market Size Estimates and Forecasts (2021-2032)
  4. 1.2.2 Global NK-1 Receptor Antagonists Sales Estimates and Forecasts (2021-2032)
  5. 1.3 NK-1 Receptor Antagonists Market by Type
  6. 1.3.1 Netupitant
  7. 1.3.2 Maropitant
  8. 1.3.3 Rolapitant
  9. 1.3.4 Fosaprepitant
  10. 1.3.5 Aprepitant
  11. 1.3.6 Other
  12. 1.4 Global NK-1 Receptor Antagonists Market Size by Type
  13. 1.4.1 Global NK-1 Receptor Antagonists Market Size Overview by Type (2021-2032)
  14. 1.4.2 Global NK-1 Receptor Antagonists Historic Market Size Review by Type (2021-2026)
  15. 1.4.3 Global NK-1 Receptor Antagonists Forecasted Market Size by Type (2027-2032)
  16. 1.5 Key Regions Market Size by Type
  17. 1.5.1 North America NK-1 Receptor Antagonists Sales Breakdown by Type (2021-2026)
  18. 1.5.2 Europe NK-1 Receptor Antagonists Sales Breakdown by Type (2021-2026)
  19. 1.5.3 Asia-Pacific NK-1 Receptor Antagonists Sales Breakdown by Type (2021-2026)
  20. 1.5.4 South America NK-1 Receptor Antagonists Sales Breakdown by Type (2021-2026)
  21. 1.5.5 Middle East and Africa NK-1 Receptor Antagonists Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
  1. 2.1 NK-1 Receptor Antagonists Industry Trends
  2. 2.2 NK-1 Receptor Antagonists Industry Drivers
  3. 2.3 NK-1 Receptor Antagonists Industry Opportunities and Challenges
  4. 2.4 NK-1 Receptor Antagonists Industry Restraints
3 Market Competitive Landscape by Company
  1. 3.1 Global Top Players by NK-1 Receptor Antagonists Revenue (2021-2026)
  2. 3.2 Global Top Players by NK-1 Receptor Antagonists Sales (2021-2026)
  3. 3.3 Global Top Players by NK-1 Receptor Antagonists Price (2021-2026)
  4. 3.4 Global NK-1 Receptor Antagonists Industry Company Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global NK-1 Receptor Antagonists Major Company Production Sites & Headquarters
  6. 3.6 Global NK-1 Receptor Antagonists Company, Product Type & Application
  7. 3.7 Global NK-1 Receptor Antagonists Company Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global NK-1 Receptor Antagonists Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 NK-1 Receptor Antagonists Players Market Share by Revenue in 2025
  11. 3.8.3 2025 NK-1 Receptor Antagonists Tier 1, Tier 2, and Tier 3
4 NK-1 Receptor Antagonists Regional Status and Outlook
  1. 4.1 Global NK-1 Receptor Antagonists Market Size and CAGR by Region: 2021 VS 2025 VS 2032
  2. 4.2 Global NK-1 Receptor Antagonists Historic Market Size by Region
  3. 4.2.1 Global NK-1 Receptor Antagonists Sales in Volume by Region (2021-2026)
  4. 4.2.2 Global NK-1 Receptor Antagonists Sales in Value by Region (2021-2026)
  5. 4.2.3 Global NK-1 Receptor Antagonists Sales (Volume & Value), Price and Gross Margin (2021-2026)
  6. 4.3 Global NK-1 Receptor Antagonists Forecasted Market Size by Region
  7. 4.3.1 Global NK-1 Receptor Antagonists Sales in Volume by Region (2027-2032)
  8. 4.3.2 Global NK-1 Receptor Antagonists Sales in Value by Region (2027-2032)
  9. 4.3.3 Global NK-1 Receptor Antagonists Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 NK-1 Receptor Antagonists by Application
  1. 5.1 NK-1 Receptor Antagonists Market by Application
  2. 5.1.1 Chemotherapy-induced Nausea and Vomiting (CINV)
  3. 5.1.2 Postoperative Nausea and Vomiting (PONV)
  4. 5.1.3 Other
  5. 5.2 Global NK-1 Receptor Antagonists Market Size by Application
  6. 5.2.1 Global NK-1 Receptor Antagonists Market Size Overview by Application (2021-2032)
  7. 5.2.2 Global NK-1 Receptor Antagonists Historic Market Size Review by Application (2021-2026)
  8. 5.2.3 Global NK-1 Receptor Antagonists Forecasted Market Size by Application (2027-2032)
  9. 5.3 Key Regions Market Size by Application
  10. 5.3.1 North America NK-1 Receptor Antagonists Sales Breakdown by Application (2021-2026)
  11. 5.3.2 Europe NK-1 Receptor Antagonists Sales Breakdown by Application (2021-2026)
  12. 5.3.3 Asia-Pacific NK-1 Receptor Antagonists Sales Breakdown by Application (2021-2026)
  13. 5.3.4 South America NK-1 Receptor Antagonists Sales Breakdown by Application (2021-2026)
  14. 5.3.5 Middle East and Africa NK-1 Receptor Antagonists Sales Breakdown by Application (2021-2026)
6 Company Profiles
  1. 6.1 Dr. Reddy's Laboratories
  2. 6.1.1 Dr. Reddy's Laboratories Company Information
  3. 6.1.2 Dr. Reddy's Laboratories Business Overview
  4. 6.1.3 Dr. Reddy's Laboratories NK-1 Receptor Antagonists Sales, Revenue and Gross Margin (2021-2026)
  5. 6.1.4 Dr. Reddy's Laboratories NK-1 Receptor Antagonists Product Portfolio
  6. 6.1.5 Dr. Reddy's Laboratories Recent Developments
  7. 6.2 Eugia Pharma
  8. 6.2.1 Eugia Pharma Company Information
  9. 6.2.2 Eugia Pharma Business Overview
  10. 6.2.3 Eugia Pharma NK-1 Receptor Antagonists Sales, Revenue and Gross Margin (2021-2026)
  11. 6.2.4 Eugia Pharma NK-1 Receptor Antagonists Product Portfolio
  12. 6.2.5 Eugia Pharma Recent Developments
  13. 6.3 Fresenius Kabi
  14. 6.3.1 Fresenius Kabi Company Information
  15. 6.3.2 Fresenius Kabi Business Overview
  16. 6.3.3 Fresenius Kabi NK-1 Receptor Antagonists Sales, Revenue and Gross Margin (2021-2026)
  17. 6.3.4 Fresenius Kabi NK-1 Receptor Antagonists Product Portfolio
  18. 6.3.5 Fresenius Kabi Recent Developments
  19. 6.4 Glenmark
  20. 6.4.1 Glenmark Company Information
  21. 6.4.2 Glenmark Business Overview
  22. 6.4.3 Glenmark NK-1 Receptor Antagonists Sales, Revenue and Gross Margin (2021-2026)
  23. 6.4.4 Glenmark NK-1 Receptor Antagonists Product Portfolio
  24. 6.4.5 Glenmark Recent Developments
  25. 6.5 Helsinn Healthcare
  26. 6.5.1 Helsinn Healthcare Company Information
  27. 6.5.2 Helsinn Healthcare Business Overview
  28. 6.5.3 Helsinn Healthcare NK-1 Receptor Antagonists Sales, Revenue and Gross Margin (2021-2026)
  29. 6.5.4 Helsinn Healthcare NK-1 Receptor Antagonists Product Portfolio
  30. 6.5.5 Helsinn Healthcare Recent Developments
  31. 6.6 Heron Therapeutics
  32. 6.6.1 Heron Therapeutics Company Information
  33. 6.6.2 Heron Therapeutics Business Overview
  34. 6.6.3 Heron Therapeutics NK-1 Receptor Antagonists Sales, Revenue and Gross Margin (2021-2026)
  35. 6.6.4 Heron Therapeutics NK-1 Receptor Antagonists Product Portfolio
  36. 6.6.5 Heron Therapeutics Recent Developments
  37. 6.7 Lupin
  38. 6.7.1 Lupin Company Information
  39. 6.7.2 Lupin Business Overview
  40. 6.7.3 Lupin NK-1 Receptor Antagonists Sales, Revenue and Gross Margin (2021-2026)
  41. 6.7.4 Lupin NK-1 Receptor Antagonists Product Portfolio
  42. 6.7.5 Lupin Recent Developments
  43. 6.8 MSN
  44. 6.8.1 MSN Company Information
  45. 6.8.2 MSN Business Overview
  46. 6.8.3 MSN NK-1 Receptor Antagonists Sales, Revenue and Gross Margin (2021-2026)
  47. 6.8.4 MSN NK-1 Receptor Antagonists Product Portfolio
  48. 6.8.5 MSN Recent Developments
  49. 6.9 Mylan
  50. 6.9.1 Mylan Company Information
  51. 6.9.2 Mylan Business Overview
  52. 6.9.3 Mylan NK-1 Receptor Antagonists Sales, Revenue and Gross Margin (2021-2026)
  53. 6.9.4 Mylan NK-1 Receptor Antagonists Product Portfolio
  54. 6.9.5 Mylan Recent Developments
  55. 6.10 Steriscience
  56. 6.10.1 Steriscience Company Information
  57. 6.10.2 Steriscience Business Overview
  58. 6.10.3 Steriscience NK-1 Receptor Antagonists Sales, Revenue and Gross Margin (2021-2026)
  59. 6.10.4 Steriscience NK-1 Receptor Antagonists Product Portfolio
  60. 6.10.5 Steriscience Recent Developments
  61. 6.11 TerSera Therapeutics
  62. 6.11.1 TerSera Therapeutics Company Information
  63. 6.11.2 TerSera Therapeutics Business Overview
  64. 6.11.3 TerSera Therapeutics NK-1 Receptor Antagonists Sales, Revenue and Gross Margin (2021-2026)
  65. 6.11.4 TerSera Therapeutics NK-1 Receptor Antagonists Product Portfolio
  66. 6.11.5 TerSera Therapeutics Recent Developments
  67. 6.12 Teva
  68. 6.12.1 Teva Company Information
  69. 6.12.2 Teva Business Overview
  70. 6.12.3 Teva NK-1 Receptor Antagonists Sales, Revenue and Gross Margin (2021-2026)
  71. 6.12.4 Teva NK-1 Receptor Antagonists Product Portfolio
  72. 6.12.5 Teva Recent Developments
  73. 6.13 Torrent Pharmaceuticals
  74. 6.13.1 Torrent Pharmaceuticals Company Information
  75. 6.13.2 Torrent Pharmaceuticals Business Overview
  76. 6.13.3 Torrent Pharmaceuticals NK-1 Receptor Antagonists Sales, Revenue and Gross Margin (2021-2026)
  77. 6.13.4 Torrent Pharmaceuticals NK-1 Receptor Antagonists Product Portfolio
  78. 6.13.5 Torrent Pharmaceuticals Recent Developments
  79. 6.14 Beijing Sihuan Pharmaceutical
  80. 6.14.1 Beijing Sihuan Pharmaceutical Company Information
  81. 6.14.2 Beijing Sihuan Pharmaceutical Business Overview
  82. 6.14.3 Beijing Sihuan Pharmaceutical NK-1 Receptor Antagonists Sales, Revenue and Gross Margin (2021-2026)
  83. 6.14.4 Beijing Sihuan Pharmaceutical NK-1 Receptor Antagonists Product Portfolio
  84. 6.14.5 Beijing Sihuan Pharmaceutical Recent Developments
  85. 6.15 Hansoh Pharma
  86. 6.15.1 Hansoh Pharma Company Information
  87. 6.15.2 Hansoh Pharma Business Overview
  88. 6.15.3 Hansoh Pharma NK-1 Receptor Antagonists Sales, Revenue and Gross Margin (2021-2026)
  89. 6.15.4 Hansoh Pharma NK-1 Receptor Antagonists Product Portfolio
  90. 6.15.5 Hansoh Pharma Recent Developments
  91. 6.16 Merck
  92. 6.16.1 Merck Company Information
  93. 6.16.2 Merck Business Overview
  94. 6.16.3 Merck NK-1 Receptor Antagonists Sales, Revenue and Gross Margin (2021-2026)
  95. 6.16.4 Merck NK-1 Receptor Antagonists Product Portfolio
  96. 6.16.5 Merck Recent Developments
  97. 6.17 Qilu Pharmaceutical
  98. 6.17.1 Qilu Pharmaceutical Company Information
  99. 6.17.2 Qilu Pharmaceutical Business Overview
  100. 6.17.3 Qilu Pharmaceutical NK-1 Receptor Antagonists Sales, Revenue and Gross Margin (2021-2026)
  101. 6.17.4 Qilu Pharmaceutical NK-1 Receptor Antagonists Product Portfolio
  102. 6.17.5 Qilu Pharmaceutical Recent Developments
  103. 6.18 Sandoz
  104. 6.18.1 Sandoz Company Information
  105. 6.18.2 Sandoz Business Overview
  106. 6.18.3 Sandoz NK-1 Receptor Antagonists Sales, Revenue and Gross Margin (2021-2026)
  107. 6.18.4 Sandoz NK-1 Receptor Antagonists Product Portfolio
  108. 6.18.5 Sandoz Recent Developments
  109. 6.19 Yichang Humanwell Pharmaceutical
  110. 6.19.1 Yichang Humanwell Pharmaceutical Company Information
  111. 6.19.2 Yichang Humanwell Pharmaceutical Business Overview
  112. 6.19.3 Yichang Humanwell Pharmaceutical NK-1 Receptor Antagonists Sales, Revenue and Gross Margin (2021-2026)
  113. 6.19.4 Yichang Humanwell Pharmaceutical NK-1 Receptor Antagonists Product Portfolio
  114. 6.19.5 Yichang Humanwell Pharmaceutical Recent Developments
  115. 6.20 Chia Tai Tianqing Pharmaceutical
  116. 6.20.1 Chia Tai Tianqing Pharmaceutical Company Information
  117. 6.20.2 Chia Tai Tianqing Pharmaceutical Business Overview
  118. 6.20.3 Chia Tai Tianqing Pharmaceutical NK-1 Receptor Antagonists Sales, Revenue and Gross Margin (2021-2026)
  119. 6.20.4 Chia Tai Tianqing Pharmaceutical NK-1 Receptor Antagonists Product Portfolio
  120. 6.20.5 Chia Tai Tianqing Pharmaceutical Recent Developments
7 North America by Country
  1. 7.1 North America NK-1 Receptor Antagonists Sales by Country
  2. 7.1.1 North America NK-1 Receptor Antagonists Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 7.1.2 North America NK-1 Receptor Antagonists Sales by Country (2021-2026)
  4. 7.1.3 North America NK-1 Receptor Antagonists Sales Forecast by Country (2027-2032)
  5. 7.2 North America NK-1 Receptor Antagonists Market Size by Country
  6. 7.2.1 North America NK-1 Receptor Antagonists Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 7.2.2 North America NK-1 Receptor Antagonists Market Size by Country (2021-2026)
  8. 7.2.3 North America NK-1 Receptor Antagonists Market Size Forecast by Country (2027-2032)
8 Europe by Country
  1. 8.1 Europe NK-1 Receptor Antagonists Sales by Country
  2. 8.1.1 Europe NK-1 Receptor Antagonists Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 8.1.2 Europe NK-1 Receptor Antagonists Sales by Country (2021-2026)
  4. 8.1.3 Europe NK-1 Receptor Antagonists Sales Forecast by Country (2027-2032)
  5. 8.2 Europe NK-1 Receptor Antagonists Market Size by Country
  6. 8.2.1 Europe NK-1 Receptor Antagonists Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 8.2.2 Europe NK-1 Receptor Antagonists Market Size by Country (2021-2026)
  8. 8.2.3 Europe NK-1 Receptor Antagonists Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
  1. 9.1 Asia-Pacific NK-1 Receptor Antagonists Sales by Country
  2. 9.1.1 Asia-Pacific NK-1 Receptor Antagonists Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 9.1.2 Asia-Pacific NK-1 Receptor Antagonists Sales by Country (2021-2026)
  4. 9.1.3 Asia-Pacific NK-1 Receptor Antagonists Sales Forecast by Country (2027-2032)
  5. 9.2 Asia-Pacific NK-1 Receptor Antagonists Market Size by Country
  6. 9.2.1 Asia-Pacific NK-1 Receptor Antagonists Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 9.2.2 Asia-Pacific NK-1 Receptor Antagonists Market Size by Country (2021-2026)
  8. 9.2.3 Asia-Pacific NK-1 Receptor Antagonists Market Size Forecast by Country (2027-2032)
10 South America by Country
  1. 10.1 South America NK-1 Receptor Antagonists Sales by Country
  2. 10.1.1 South America NK-1 Receptor Antagonists Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 10.1.2 South America NK-1 Receptor Antagonists Sales by Country (2021-2026)
  4. 10.1.3 South America NK-1 Receptor Antagonists Sales Forecast by Country (2027-2032)
  5. 10.2 South America NK-1 Receptor Antagonists Market Size by Country
  6. 10.2.1 South America NK-1 Receptor Antagonists Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 10.2.2 South America NK-1 Receptor Antagonists Market Size by Country (2021-2026)
  8. 10.2.3 South America NK-1 Receptor Antagonists Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
  1. 11.1 Middle East and Africa NK-1 Receptor Antagonists Sales by Country
  2. 11.1.1 Middle East and Africa NK-1 Receptor Antagonists Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 11.1.2 Middle East and Africa NK-1 Receptor Antagonists Sales by Country (2021-2026)
  4. 11.1.3 Middle East and Africa NK-1 Receptor Antagonists Sales Forecast by Country (2027-2032)
  5. 11.2 Middle East and Africa NK-1 Receptor Antagonists Market Size by Country
  6. 11.2.1 Middle East and Africa NK-1 Receptor Antagonists Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 11.2.2 Middle East and Africa NK-1 Receptor Antagonists Market Size by Country (2021-2026)
  8. 11.2.3 Middle East and Africa NK-1 Receptor Antagonists Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
  1. 12.1 NK-1 Receptor Antagonists Value Chain Analysis
  2. 12.1.1 NK-1 Receptor Antagonists Key Raw Materials
  3. 12.1.2 Key Raw Materials Price
  4. 12.1.3 Raw Materials Key Suppliers
  5. 12.1.4 Manufacturing Cost Structure
  6. 12.1.5 NK-1 Receptor Antagonists Production Mode & Process
  7. 12.2 NK-1 Receptor Antagonists Sales Channels Analysis
  8. 12.2.1 Direct Comparison with Distribution Share
  9. 12.2.2 NK-1 Receptor Antagonists Distributors
  10. 12.2.3 NK-1 Receptor Antagonists Customers
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources
    8. 14.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst